LTFS
IMUC

Ladenburg Thalmann Financial Services’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-45
Closed – – 5218
2017
Q2 		$0 Hold
45
– – ﹤0.01% 5162
2017
Q1 		$0 Sell
45
-25
-36% -$65 ﹤0.01% 5170
2016
Q4 		$0 Hold
70
– – ﹤0.01% 5139
2016
Q3 		$0 Hold
70
– – ﹤0.01% 5094
2016
Q2 		$0 Buy
70
+25
+56% +$257 ﹤0.01% 5075
2016
Q1 		$1K Hold
45
– – ﹤0.01% 4657
2015
Q4 		$1K Hold
45
– – ﹤0.01% 4648
2015
Q3 		$1K Hold
45
– – ﹤0.01% 4573
2015
Q2 		$1K Hold
45
– – ﹤0.01% 4625
2015
Q1 		$1K Hold
45
– – ﹤0.01% 4550
2014
Q4 		$1K Buy
45
+20
+80% +$576 ﹤0.01% 4328
2014
Q3 		$1K Hold
25
– – ﹤0.01% 3900
2014
Q2 		$1K Hold
25
– – ﹤0.01% 3869
2014
Q1 		$1K Buy
+25
New +$1.22K ﹤0.01% 3729

Other funds holding IMUC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return